Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $110,734 - $156,844
-34,932 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$2.98 - $5.2 $52,820 - $92,170
-17,725 Reduced 33.66%
34,932 $140,000
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $120,584 - $223,265
52,657 New
52,657 $207,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.